EcoR1 Capital, LLC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 49 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2021$75,000
-98.4%
7,001
-98.7%
0.00%
-98.3%
Q2 2021$4,704,000
-40.1%
522,635
-29.5%
0.18%
-49.6%
Q1 2021$7,858,000
-15.9%
741,2900.0%0.35%
-30.5%
Q4 2020$9,340,000
+43.3%
741,2900.0%0.50%
+8.0%
Q3 2020$6,516,000741,2900.46%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders